Targeted Therapy for Chronic Lymphocytic Leukemia: A Glimpse Into the Future

被引：2
|
作者：
Hillmen, Peter [1 ]
机构：
[1] St Jamess Inst Oncol, Leeds, W Yorkshire, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 05期
关键词：
PHASE-I; SURVIVAL; BCL-2;
D O I：
10.1200/JCO.2011.37.8612
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：469 / 470
页数：2
相关论文
共 50 条
  • [21] Targeted Agents in Chronic Lymphocytic Leukemia
    O'Brien, Susan M.
    Smith, Ashbel
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (01) : 9 - 11
  • [22] Rare case of chronic lymphocytic leukemia in an adolescent treated with targeted therapy
    Nash, Ariel
    Weirda, William
    Albritton, Karen
    Cuglievan, Branko
    Garcia, Miriam
    Mccall, David
    Nunez, Cesar
    Gibson, Amber
    PEDIATRIC BLOOD & CANCER, 2024, 71 (09)
  • [23] CD126 and Targeted Therapy with Tocilizumab in Chronic Lymphocytic Leukemia
    Liu, Feng-Ting
    Jia, Li
    Wang, Ping
    Farren, Timothy
    Li, Hong
    Hao, Xishan
    Agrawal, Samir G.
    CLINICAL CANCER RESEARCH, 2016, 22 (10) : 2462 - 2469
  • [24] Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia
    Robak, Tadeusz
    Blonski, Jerzy Z.
    Robak, Pawel
    SEMINARS IN ONCOLOGY, 2016, 43 (02) : 280 - 290
  • [25] The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
    Landau, Dan A.
    Sun, Clare
    Rosebrock, Daniel
    Herman, Sarah E. M.
    Fein, Joshua
    Sivina, Mariela
    Underbayev, Chingiz
    Liu, Delong
    Hoellenriegel, Julia
    Ravichandran, Sarangan
    Farooqui, Mohammed Z. H.
    Zhang, Wandi
    Cibulskis, Carrie
    Zviran, Asaf
    Neuberg, Donna S.
    Livitz, Dimitri
    Bozic, Ivana
    Leshchiner, Ignaty
    Getz, Gad
    Burger, Jan A.
    Wiestner, Adrian
    Wu, Catherine J.
    NATURE COMMUNICATIONS, 2017, 8
  • [26] The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
    Dan A. Landau
    Clare Sun
    Daniel Rosebrock
    Sarah E. M. Herman
    Joshua Fein
    Mariela Sivina
    Chingiz Underbayev
    Delong Liu
    Julia Hoellenriegel
    Sarangan Ravichandran
    Mohammed Z. H. Farooqui
    Wandi Zhang
    Carrie Cibulskis
    Asaf Zviran
    Donna S. Neuberg
    Dimitri Livitz
    Ivana Bozic
    Ignaty Leshchiner
    Gad Getz
    Jan A. Burger
    Adrian Wiestner
    Catherine J. Wu
    Nature Communications, 8
  • [27] Incidence of Richter transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma in the targeted therapy era
    Hampel, Paul J.
    Rabe, Kari G.
    Wang, Yucai
    Hwang, Steven R.
    Kenderian, Saad S.
    Muchtar, Eli
    Leis, Jose F.
    Koehler, Amber B.
    Tsang, Mazie
    Hilal, Talal
    Parrondo, Ricardo
    Bailen, Rachel J.
    Schwager, Susan M.
    Hanson, Curtis A.
    Braggio, Esteban
    Slager, Susan L.
    Shi, Min
    Zepeda-Mendoza, Cinthya J.
    Van Dyke, Daniel L.
    Shanafelt, Tait D.
    King, Rebecca L.
    Call, Timothy G.
    Kay, Neil E.
    Ding, Wei
    Parikh, Sameer A.
    LEUKEMIA, 2025, 39 (02) : 503 - 507
  • [28] Redefining efficacy and safety endpoints for chronic lymphocytic leukemia in the era of targeted therapy
    Molica, Stefano
    EXPERT REVIEW OF HEMATOLOGY, 2023, 16 (11) : 803 - 806
  • [29] The role of chemotherapy in managing chronic lymphocytic leukemia: optimizing combinations with targeted therapy
    Nastoupil, Loretta J.
    Sinha, Rajni
    Flowers, Christopher R.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (09) : 1089 - 1108
  • [30] Will combination therapy with targeted drugs be better for achieving remission in chronic lymphocytic leukemia?
    Robak, Tadeusz
    EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (16) : 1675 - 1678
12345